NYSE:EVHEvolent Health Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Evolent Health Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $13.06 -0.29 (-2.17 %) (As of 08/7/2020 04:00 PM ET) Add Compare Share Today's Range$12.60Now: $13.06▼$13.3350-Day Range$6.00MA: $8.85▼$13.3552-Week Range$3.50Now: $13.06▼$13.36Volume1.31 million shsAverage Volume1.70 million shsMarket Capitalization$1.12 billionP/E RatioN/ADividend YieldN/ABeta1.91 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management. Its services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More Beat the Market (BTM) Rank™ 2.4 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.56, Evolent Health has a potential upside of 3.8% from its current price of $13.06.Amount of Analyst CoverageEvolent Health has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.1 Community Rank Outperform VotesEvolent Health has received 489 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEvolent Health has received 299 “underperform” votes. (Add your “underperform” vote.)Community SentimentEvolent Health has received 62.06% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Evolent Health and other stocks. Vote “Outperform” if you believe EVH will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EVH will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $130,100.00 in company stock.Percentage Held by InsidersOnly 5.00% of the stock of Evolent Health is held by insiders.Percentage Held by Institutions89.08% of the stock of Evolent Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to decrease in the coming year, from ($0.53) to ($0.54) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -2.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 1.19. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.4Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.29 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Management services Sub-IndustryN/A SectorComputer and Technology Current SymbolNYSE:EVH Previous Symbol CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone571-389-6000Debt Debt-to-Equity Ratio0.42 Current Ratio1.09 Quick Ratio1.09Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$846.38 million Price / Sales1.32 Cash Flow$2.36 per share Price / Cash Flow5.53 Book Value$10.98 per share Price / Book1.19Profitability EPS (Most Recent Fiscal Year)($0.91) Net Income$-301,970,000.00 Net Margins-53.56% Return on Equity-4.29% Return on Assets-2.67%Miscellaneous Employees3,400 Outstanding Shares85,480,000Market Cap$1.12 billion Next Earnings Date11/3/2020 (Estimated) OptionableOptionable $13.06 -0.29 (-2.17 %) (As of 08/7/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive EVH News and Ratings via Email Sign-up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter. Evolent Health (NYSE:EVH) Frequently Asked Questions How has Evolent Health's stock been impacted by COVID-19 (Coronavirus)? Evolent Health's stock was trading at $6.92 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EVH shares have increased by 88.7% and is now trading at $13.06. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Evolent Health? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Evolent Health. When is Evolent Health's next earnings date? Evolent Health is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for Evolent Health. How were Evolent Health's earnings last quarter? Evolent Health Inc (NYSE:EVH) posted its quarterly earnings data on Tuesday, August, 4th. The technology company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.17) by $0.14. Evolent Health had a negative return on equity of 4.29% and a negative net margin of 53.56%. View Evolent Health's earnings history. What guidance has Evolent Health issued on next quarter's earnings? Evolent Health updated its FY 2020 After-Hours earnings guidance on Tuesday, August, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $995M - 1.035 billion, compared to the consensus revenue estimate of $977.85 million. What price target have analysts set for EVH? 11 analysts have issued twelve-month price objectives for Evolent Health's stock. Their forecasts range from $8.00 to $20.00. On average, they expect Evolent Health's share price to reach $13.56 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View analysts' price targets for Evolent Health. Has Evolent Health been receiving favorable news coverage? Media coverage about EVH stock has trended extremely negative on Sunday, according to InfoTrie. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Evolent Health earned a daily sentiment score of -4.8 on InfoTrie's scale. They also assigned headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Evolent Health. Who are some of Evolent Health's key competitors? Some companies that are related to Evolent Health include Premier (PINC), Mantech International (MANT), R1 RCM (RCM), Franklin Covey (FC), Jupai (JP), PHI Group (PHIL) and Rainmaker Systems (VCTL). View all competitors. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Chipotle Mexican Grill (CMG), Energy Transfer LP Unit (ET), Netflix (NFLX), Micron Technology (MU), Advanced Micro Devices (AMD) and Aegean Marine Petroleum Network (ANW). Who are Evolent Health's key executives? Evolent Health's management team includes the following people: Mr. Frank J. Williams, Co-Founder, CEO & Chairman (Age 52)Mr. Seth Blackley, Co-Founder, Pres & Director (Age 40)Mr. Thomas Peterson III, Co-Founder & COO (Age 49)Mr. Nicholas McGrane, Chief Financial Officer (Age 51)Ms. Lydia Stone, VP, Chief Accounting Officer & Controller (Age 43) When did Evolent Health IPO? (EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. What is Evolent Health's stock symbol? Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH." Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Peregrine Capital Management LLC (1.36%), DC Investments Management LLC (1.36%), Profit Investment Management LLC (0.24%), Swiss National Bank (0.20%), New York State Common Retirement Fund (0.14%) and Paradigm Capital Management Inc. NY (0.07%). Company insiders that own Evolent Health stock include Doug S Aron, Frank J Williams, Jonathan Weinberg, Kenneth A Samet, Lydia Stone, Michael D'amato, Seth Blackley and Thomas Peterson III. View institutional ownership trends for Evolent Health. Which major investors are selling Evolent Health stock? EVH stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Peregrine Capital Management LLC, and US Bancorp DE. View insider buying and selling activity for Evolent Health. Which major investors are buying Evolent Health stock? EVH stock was bought by a variety of institutional investors in the last quarter, including DC Investments Management LLC, Profit Investment Management LLC, Paradigm Capital Management Inc. NY, New York State Common Retirement Fund, Swiss National Bank, WoodTrust Financial Corp, SeaCrest Wealth Management LLC, and ProShare Advisors LLC. Company insiders that have bought Evolent Health stock in the last two years include Doug S Aron, Kenneth A Samet, Michael D'amato, and Seth Blackley. View insider buying and selling activity for Evolent Health. How do I buy shares of Evolent Health? Shares of EVH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Evolent Health's stock price today? One share of EVH stock can currently be purchased for approximately $13.06. How big of a company is Evolent Health? Evolent Health has a market capitalization of $1.12 billion and generates $846.38 million in revenue each year. The technology company earns $-301,970,000.00 in net income (profit) each year or ($0.91) on an earnings per share basis. Evolent Health employs 3,400 workers across the globe. What is Evolent Health's official website? The official website for Evolent Health is www.evolenthealth.com. How can I contact Evolent Health? Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The technology company can be reached via phone at 571-389-6000. This page was last updated on 8/9/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
